Phase 3-ready biotech developing immunotherapies for melanoma and other cancers.
Industry: Health Care
Latest Trade: $1.15 0.00 (0.0%)
First Day Return: +11.8%
Return from IPO: -91.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/15/2021 |
Offer Price | $14.00 |
Price Range $14.00 - $17.00 | |
Offer Shares (mm) | 7.2 |
Deal Size ($mm) | $100 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 11/04/2021 |
Offer Price | $14.00 |
Price Range $14.00 - $17.00 | |
Offer Shares (mm) | 7.2 |
Deal Size ($mm) | $100 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Morgan Stanley |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Copenhagen, Denmark |
Founded | 2014 |
Employees at IPO | 19 |
Website www.iobiotech.com |